Biotechnology advances the plastics industry by employing living cells and enzymes to create eco-friendly solutions and ...

ChemT Biotechnology的创始团队包含拥有哈佛大学公共卫生硕士学位的孙洁、曾为新加坡国立大学医学系客座研究员的吴凌，以及T细胞生物学领域知名专家加斯科因（Nicholas Gascoigne）教授等三人。

Despite biotech's struggles, quality and global diversification create opportunities in select names. Read why portfolio ...

May 8, 2025 — A recent study marks the first reported instance of generative AI designing synthetic molecules that can successfully control gene expression in healthy mammalian cells. As a proof ...

The CSIR UGC JRF-NET exam is being conducted in five science disciplines- Chemical Sciences, Earth Sciences, Life Sciences, ...

Xoted Biotechnology Labs announced plans to establish operations in the Spartanburg County. The cutting-edge research and ...

The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release.

Vir Biotech在2025年第一季度的整体表现以研发 (R&D)费用增加为特点，从2024年第一季度的$100.1百万增至$118.6百万。这一增长反映了公司对丙型肝炎Delta病毒和肿瘤学项目的持续投入。尽管销售、一般和行政 (SG&A)费用有所下降，但公司报告净亏损$121百万，较去年同期的$65.3百万亏损显著增加。

Anbio Biotechnology’s NNNN share price has surged by 5.23%, which has investors questioning if this is right time to sell.

Investing.com — Nautilus Biotechnology (NASDAQ: NAUT )公布了2025年第一季度财报，显示亏损低于预期，每股收益为-$0.13，优于预期的-$0.15。这一超预期表现使该公司股价在盘前交易中上涨7.35%，达到$0.73。公司强调了稳健的现金状况和运营支出的减少，同时继续专注于其创新的蛋白质组学平台。